IRWD icon

Ironwood Pharmaceuticals

197 hedge funds and large institutions have $520M invested in Ironwood Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 63 increasing their positions, 46 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
197
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$39.2M
Puts
$123K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BCB
126
Brian C. Broderick
$60.7K
NAM
127
NorthCrest Asset Manangement
Minnesota
$60.4K
AWM
128
Ariadne Wealth Management
California
$56.4K
Legal & General Group
129
Legal & General Group
United Kingdom
$56.2K
AHL
130
Abel Hall LLC
Louisiana
$56.1K
HighTower Advisors
131
HighTower Advisors
Illinois
$54.4K
Citigroup
132
Citigroup
New York
$52.2K
TRCT
133
Tower Research Capital (TRC)
New York
$51.1K
Neuberger Berman Group
134
Neuberger Berman Group
New York
$50.1K
EPW
135
Evolve Private Wealth
California
$49.9K
Calamos Advisors
136
Calamos Advisors
Illinois
$48.9K
AIP
137
Ameritas Investment Partners
Nebraska
$46.4K
EWA
138
EverSource Wealth Advisors
Alabama
$46.1K
FCM
139
Farallon Capital Management
California
$43.8K
DT
140
Diversified Trust
Tennessee
$42.4K
WWC
141
Waypoint Wealth Counsel
Georgia
$42.1K
X
142
Xponance
Pennsylvania
$41.9K
MM
143
MQS Management
New York
$41.8K
CCM
144
Coldstream Capital Management
Washington
$41.5K
Cetera Investment Advisers
145
Cetera Investment Advisers
Illinois
$40.3K
IWC
146
Integrated Wealth Concepts
Massachusetts
$38.5K
Mackenzie Financial
147
Mackenzie Financial
Ontario, Canada
$38.4K
EW
148
Evoke Wealth
California
$38K
SP
149
Stonebrook Private
Michigan
$37K
SAM
150
Simplify Asset Management
Nevada
$36.9K